Sector Focus

Pharmaceutical Sector

Tricap has entered into the pharmaceutical and biotechnology sector in Malaysia by partnering with a number of large global pharmaceutical firms. We have positioned in Malaysia a strong team of seasoned executives, with extensive industry experience and strong technical and managerial skills to undertake the venture.

We plan to undertake 3-4 investments in the sector over the next couple of years with a total capital outlay of US$100 million. Work has already begun on the first project in the vaccine manufacturing and packaging space, which is expected to come online in 2018.